• Education
  • Financial Transparency Project
  • Pension Reform
  • Transportation
  • Email Newsletters
  • Reason facebook
  • Reason twitter
  • Reason youtube
Reason Foundation
  • About
    • About Us
    • Contact Us
    • Email Newsletters
    • Events
    • FAQs
    • Jobs & Internships
    • Savas Award
    • Shop
    • Staff
    • Trustees & Officers
  • Experts

      Browse Our Experts

      • Aaron Smith
        Director of Education Reform
      • Adrian Moore
        Vice President of Policy
      • Baruch Feigenbaum
        Senior Managing Director, Transportation Policy
      • Geoff Lawrence
        Research Director
      • Guy Bentley
        Director of Consumer Freedom
      • Leonard Gilroy
        Vice President of Government Reform
      • Robert Poole
        Director of Transportation Policy
      • Vittorio Nastasi
        Director of Criminal Justice Policy
      • View All Experts
  • Topics

      Browse Our Topics

      • Air Traffic Control
      • Annual Highway Report
      • Consumer Freedom
      • Criminal Justice Reform
      • Drug Policy
      • Education
      • Email Newsletters
      • Gov’t Financial Transparency
      • Pension Reform
      • Technology
      • Transportation
      • View All Topics
  • Publications
    • Amicus Briefs
    • Annual Highway Report
    • Annual Pension Report
    • Annual Privatization Report
    • Aviation Newsletter
    • Backgrounders
    • Commentaries
    • Data Visualization
    • Education Newsletter
    • Email Newsletters
    • Pension Reform Newsletter
    • Policy Studies
    • Psychedelics Newsletter
    • Public Schools Without Boundaries
    • Testimony
    • Transportation Newsletter
  • Reason.com
  • Donate
    • Donate Online
    • Donate Crypto
    • Ways To Give
    • Torchbearer Society
    • Planned Giving

Topics › Drug Policy

Drug Policy

  • Industrial Hemp
  • Marijuana Regulations
  • Medical Marijuana
  • Opioid Crisis
  • Psychedelics

  • Psychedelics Policy Newsletter: Trump administration recommendations, Massachusetts loss, and more
    Psychedelics Policy Newsletter: Trump administration recommendations, Massachusetts loss, and more

    Psychedelics Policy Newsletter by Gregory Ferenstein

  • State psychedelics legalization and policy roundup — December 2024
    State psychedelics legalization and policy roundup — December 2024

    Commentary by Gregory Ferenstein

  • Psychedelic drug policy recommendations for the incoming Trump administration
    Psychedelic drug policy recommendations for the incoming Trump administration

    Backgrounder by Geoffrey Lawrence, Leonard Gilroy and Gregory Ferenstein

  • Court ruling underscores the need for sensible hemp rules in New Jersey
    Court ruling underscores the need for sensible hemp rules in New Jersey

    Commentary by Michelle Minton

  • A single cannabis retailer license type would benefit both marijuana and hemp businesses
    A single cannabis retailer license type would benefit both marijuana and hemp businesses

    Commentary by Geoffrey Lawrence

  • Banning hemp products won’t protect public health or foster fairness for marijuana businesses
    Banning hemp products won’t protect public health or foster fairness for marijuana businesses

    Commentary by Michelle Minton

  • Unreliable drug tests shouldn’t be used to separate mothers from their newborns
    Unreliable drug tests shouldn’t be used to separate mothers from their newborns

    Commentary by Layal Bou Harfouch

  • No, Florida’s marijuana measure won’t create a cannabis monopoly—as long as lawmakers don’t screw it up
    No, Florida’s marijuana measure won’t create a cannabis monopoly—as long as lawmakers don’t screw it up

    Commentary by Madison Carlino

  • Psilocybin access would improve mental health care in Massachusetts
    Psilocybin access would improve mental health care in Massachusetts

    Commentary by Gregory Ferenstein

More Drug Policy

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • ...
  • 52
  • Next

Follow

  • Facebook
  • Twitter
  • YouTube
  • RSS

Email Updates

Get weekly updates from Reason.

This field is for validation purposes and should be left unchanged.

More About Reason Foundation

  • About
  • Contact
  • Donate
  • Email Newsletters
  • Events
  • Jobs and Internships
  • Policy Research
  • Reason magazine
  • Shop

Contact

Reason Foundation
5737 Mesmer Ave.
Los Angeles, CA 90230
(310) 391-2245

1630 Connecticut Ave NW
Suite 600
Washington, DC 20009
(202) 986-0916

Privacy Policy
Accessibility

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
Copyright © 2025 Reason Foundation